๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II Trial of Neoadjuvant Nab-Paclitaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy

โœ Scribed by Shepard, D.R.; Dreicer, R.; Garcia, J.; Elson, P.; Magi-Galluzzi, C.; Raghavan, D.; Stephenson, A.J.; Klein, E.A.


Book ID
122630370
Publisher
Lippincott Williams and Wilkins
Year
2009
Tongue
English
Weight
607 KB
Volume
181
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase II trial of neoadjuvant docetaxel
โœ Jacqueline Vuky; Christopher Porter; Christina Isacson; Matthew Vaughan; Paul Ko ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 136 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND: Prostate cancer trials investigating neoadjuvant hormonal therapy, followed by surgery, have demonstrated that elimination of all tumor cells from the primary site is rare. The authors report a phase 2 trial assessing the efficacy and toxicity of docetaxel and gefitinib